Evaluation of Home Program and Telerehabilitation for the Treatment Process in Patients With Breast Cancer-Related Lymphedema

September 26, 2023 updated by: Marmara University
During the Covid-19 pandemic, rehabilitation services for all patients were affected, and a term that was previously in use but gained popularity during the pandemic entered our vocabulary: 'Telerehabilitation'. The purpose of our study is to evaluate the treatment process and adherence of patients undergoing telerehabilitation.

Study Overview

Detailed Description

Our study is a randomized single-blind prospective study. Patients aged 18 to 75 years with stage 1-2 lymphedema associated with breast cancer and upper extremity lymphedema, who had undergone breast surgery at least 3 months prior, were included in the study. Group 1: Patients were given a brochure explaining the massage and exercises they should perform. They were periodically contacted by a physiotherapist and clinician to remind them of their tasks. Group 2: Patients underwent telerehabilitation exercises and massages three times a week guided by a physiotherapist and clinician, and on the remaining days, they continued their self-administered tasks. Patients were evaluated three times: before treatment, at weeks 5 and 8 after treatment. During each visit, patients' inter-limb volume difference, Quick DASH and Life Impact Scale scores, pain, tension, stiffness, and heaviness sensations were assessed.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Marmara University School of Medicine, Pendik Education and Research Hospital, Department of Physical Medicine and Rehabilitation
      • İstanbul, Turkey, 34899
        • Canan Şanal-Toprak

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients who had undergone breast surgery at least 3 months ago
  • Had stage 1-2 lymphedema
  • Had upper extremity lymphedema associated with breast cancer

Exclusion Criteria:

  • Signs of infection such as lymphangitis, cellulitis, fungal infections
  • Those with documented lymph node metastases
  • Those with bilateral lymphedema
  • Those with other diseases affecting upper extremity functions
  • Those with a history of previous surgery related to the upper extremity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telerehabilitation Group
patients received exercises and massages through TR three times a week, conducted by a physiotherapist and a clinician. They were encouraged to perform their exercises and wear compression garments on the remaining days. Prior to the program, patients or their relatives received training from physiotherapists regarding exercises and Manual Lymphatic Drainage (MLD). Patients or their relatives were informed about the Zoom program and were instructed to acquire the application online. Two physiotherapists and groups of five patients each were organized based on rehabilitation days and hours, and access to the Zoom link was provided.

MLD:It is a unique massage technique that uses specific hand movements to provide a gentle pumping effect on the skin.

Massage movements follow the direction of lymph flow and produce rapid results. The aim of this method is to achieve maximum skin tightening effect with minimum pressure.

Exercise, on the other hand, increases physical performance, improves body composition, and provides an increase in quality of life by providing acute and chronic reductions in fatigue. Both aerobic exercises and strengthening exercises have been found effective on physical performance. It shows that a mixed program consisting of components such as aerobics, strengthening, coordination and stretching can positively affect flexibility, pain and energy expenditure in breast cancer patients.

Active Comparator: Home- Exercise Group
patients were provided with a brochure explaining the massages and exercises they needed to perform. Additionally, they were contacted three times a week by a physiotherapist and a clinician to remind them of the treatments, assess the continuity and accuracy of the treatments, encourage them to perform the treatments correctly and consistently, and promote the wearing of compression garments.

MLD:It is a unique massage technique that uses specific hand movements to provide a gentle pumping effect on the skin.

Massage movements follow the direction of lymph flow and produce rapid results. The aim of this method is to achieve maximum skin tightening effect with minimum pressure.

Exercise, on the other hand, increases physical performance, improves body composition, and provides an increase in quality of life by providing acute and chronic reductions in fatigue. Both aerobic exercises and strengthening exercises have been found effective on physical performance. It shows that a mixed program consisting of components such as aerobics, strengthening, coordination and stretching can positively affect flexibility, pain and energy expenditure in breast cancer patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Volume Measurements
Time Frame: Time Frame: Day 0
Arm measurement was measured with a tape measure at 4 cm intervals and calculated using the cone method in cm3
Time Frame: Day 0
Volume Measurements
Time Frame: Time Frame: 5 weeks
Arm measurement was measured with a tape measure at 4 cm intervals and calculated using the cone method in cm3
Time Frame: 5 weeks
Volume Measurements
Time Frame: Time Frame: 8 weeks
Arm measurement was measured with a tape measure at 4 cm intervals and calculated using the cone method in cm3
Time Frame: 8 weeks
Symptom Severity
Time Frame: Time Frame: Day 0
Shoulder pain, tightness, sensation of heaviness, and stiffness were evaluated using a numerical scale (1 to 10 points)
Time Frame: Day 0
Symptom Severity
Time Frame: Time Frame: 5 weeks
Shoulder pain, tightness, sensation of heaviness, and stiffness were evaluated using a numerical scale (1 to 10 points)
Time Frame: 5 weeks
Symptom Severity
Time Frame: Time Frame: 8 weeks
Shoulder pain, tightness, sensation of heaviness, and stiffness were evaluated using a numerical scale (1 to 10 points)
Time Frame: 8 weeks
Functionality
Time Frame: Time Frame: Day 0
Ouick Disabilities of the Arm, Shoulder and Hand (Quick DASH) questionnaire
Time Frame: Day 0
Functionality
Time Frame: Time Frame: 5 weeks
Ouick Disabilities of the Arm, Shoulder and Hand (Quick DASH) questionnaire
Time Frame: 5 weeks
Functionality
Time Frame: Time Frame: 8 weeks
Ouick Disabilities of the Arm, Shoulder and Hand (Quick DASH) questionnaire
Time Frame: 8 weeks
Efficacity
Time Frame: Time Frame: Day 0
Lymphedema Quality of Life Impact Scale
Time Frame: Day 0
Efficacity
Time Frame: Time Frame: 5 weeks
Lymphedema Quality of Life Impact Scale
Time Frame: 5 weeks
Efficacity
Time Frame: Time Frame: 8 weeks
Lymphedema Quality of Life Impact Scale
Time Frame: 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction with the treatment
Time Frame: Time Frame: 5 weeks
Responses were gathered on a scale of very satisfied - satisfied - somewhat satisfied - unsatisfied
Time Frame: 5 weeks
Patient satisfaction with the treatment
Time Frame: Time Frame: 8 weeks
Responses were gathered on a scale of very satisfied - satisfied - somewhat satisfied - unsatisfied
Time Frame: 8 weeks
patients were asked to compare their hand functionality to before the injury
Time Frame: Time Frame: 5 weeks
Responses were gathered on a scale of 'much better - somewhat better - same - somewhat worse - much worse
Time Frame: 5 weeks
patients were asked to compare their hand functionality to before the injury
Time Frame: Time Frame: 8 weeks
Responses were gathered on a scale of 'much better - somewhat better - same - somewhat worse - much worse
Time Frame: 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: CANAN ŞANAL TOPRAK, Marmara University School of Medicine, Pendik Education and Research Hospital, Department of Physical Medicine and Rehabilitation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Actual)

September 1, 2022

Study Completion (Actual)

June 1, 2023

Study Registration Dates

First Submitted

September 26, 2023

First Submitted That Met QC Criteria

September 26, 2023

First Posted (Actual)

October 3, 2023

Study Record Updates

Last Update Posted (Actual)

October 3, 2023

Last Update Submitted That Met QC Criteria

September 26, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe